SoftOx Solutions AS (SOFTX) - Total Assets
Based on the latest financial reports, SoftOx Solutions AS (SOFTX) holds total assets worth Nkr117.52 Million NOK (≈ $12.37 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SoftOx Solutions AS (SOFTX) shareholders funds for net asset value and shareholders' equity analysis.
SoftOx Solutions AS - Total Assets Trend (2016–2024)
This chart illustrates how SoftOx Solutions AS's total assets have evolved over time, based on quarterly financial data.
SoftOx Solutions AS - Asset Composition Analysis
Current Asset Composition (December 2024)
SoftOx Solutions AS's total assets of Nkr117.52 Million consist of 8.7% current assets and 91.3% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr10.51 Million | 8.7% |
| Accounts Receivable | Nkr0.00 | 0.0% |
| Inventory | Nkr0.00 | 0.0% |
| Property, Plant & Equipment | Nkr0.00 | 0.0% |
| Intangible Assets | Nkr26.41 Million | 21.8% |
| Goodwill | Nkr0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how SoftOx Solutions AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SoftOx Solutions AS (SOFTX) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SoftOx Solutions AS's current assets represent 8.7% of total assets in 2024, a decrease from 24.2% in 2016.
- Cash Position: Cash and equivalents constituted 8.7% of total assets in 2024, up from 3.4% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, a decrease from 68.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 21.8% of total assets.
SoftOx Solutions AS Competitors by Total Assets
Key competitors of SoftOx Solutions AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT
|
USA | $107.75 Million |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
|
USA | $1.53 Billion |
|
Inner Mongolia Furui Med Sci
SHE:300049
|
China | CN¥3.42 Billion |
|
Bio-Thera Solutions Ltd
SHG:688177
|
China | CN¥2.39 Billion |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥4.75 Billion |
|
Gubra A/S
CO:GUBRA
|
Denmark | Dkr1.32 Billion |
SoftOx Solutions AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 0.88 | 4.21 |
| Quick Ratio | 1.16 | 0.88 | 3.95 |
| Cash Ratio | 0.00 | 0.83 | 0.00 |
| Working Capital | Nkr2.80 Million | Nkr-2.03 Million | Nkr35.64 Million |
SoftOx Solutions AS - Advanced Valuation Insights
This section examines the relationship between SoftOx Solutions AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.71 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 24.6% |
| Total Assets | Nkr121.14 Million |
| Market Capitalization | $30.08 Million USD |
Valuation Analysis
Below Book Valuation: The market values SoftOx Solutions AS's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: SoftOx Solutions AS's assets grew by 24.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SoftOx Solutions AS (2016–2024)
The table below shows the annual total assets of SoftOx Solutions AS from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr121.14 Million ≈ $12.75 Million |
+24.58% |
| 2023-12-31 | Nkr97.24 Million ≈ $10.23 Million |
+24.93% |
| 2022-12-31 | Nkr77.83 Million ≈ $8.19 Million |
-27.38% |
| 2021-12-31 | Nkr107.18 Million ≈ $11.28 Million |
+22.75% |
| 2020-12-31 | Nkr87.31 Million ≈ $9.19 Million |
-16.82% |
| 2019-12-31 | Nkr104.96 Million ≈ $11.05 Million |
+348.69% |
| 2018-12-31 | Nkr23.39 Million ≈ $2.46 Million |
-24.63% |
| 2017-12-31 | Nkr31.04 Million ≈ $3.27 Million |
+250.31% |
| 2016-12-31 | Nkr8.86 Million ≈ $932.31K |
-- |
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more